Decrementing expiratory neurons of the Botzinger complex. I. Response to lung inflation and axonal projection.
Manabe M, Ezure K.
Exp Brain Res. 1988;72(1):150-8. doi: 10.1007/BF00248510.
Repetitive stimulation in myasthenia gravis: decrementing response revealed by anticholinesterase drugs.
Scoppetta C, Casali C, D'Agostini S, La Cesa I, Parisi L.
Electroencephalogr Clin Neurophysiol. 1990 Feb;75(2):122-4. doi: 10.1016/0013-4694(90)90160-l.
Psychogenic parkinsonism.
Lang AE, Koller WC, Fahn S.
Arch Neurol. 1995 Aug;52(8):802-10. doi: 10.1001/archneur.1995.00540320078015.
Behavior-decrementing effects of low doses of haloperidol result from disruptions in response force and duration.
Fowler SC, Kirkpatrick MA.
Behav Pharmacol. 1989;1(2):123-132.
A decrementing form of plasticity apparent in cerebellar learning.
Ohyama T, Voicu H, Kalmbach B, Mauk MD.
J Neurosci. 2010 Dec 15;30(50):16993-7003. doi: 10.1523/JNEUROSCI.2455-10.2010.
Botzinger expiratory neurones inhibit propriobulbar decrementing inspiratory neurones.
Duffin J, Douse MA.
Neuroreport. 1993 Sep 10;4(11):1215-8. doi: 10.1097/00001756-199309000-00001.
Hormesis, Gompertz functions, and risk assessment.
Boxenbaum H, Neafsey PJ, Fournier DJ.
Drug Metab Rev. 1988;19(2):195-229. doi: 10.3109/03602538809049623.
Equal response rates maintained by concurrent drug and nondrug reinforcers: a design for treatment evaluation.
Meisch RA, Gomez TH, Lane SD.
Behav Pharmacol. 2020 Aug;31(5):458-464. doi: 10.1097/FBP.0000000000000525.
Optimization of aminoglycoside therapy.
Drusano GL, Louie A.
Antimicrob Agents Chemother. 2011 Jun;55(6):2528-31. doi: 10.1128/AAC.01314-10. Epub 2011 Mar 14.
Control of forelimb muscle activity by populations of corticomotoneuronal and rubromotoneuronal cells.
Fetz EE, Cheney PD, Mewes K, Palmer S.
Prog Brain Res. 1989;80:437-49; discussion 427-30. doi: 10.1016/s0079-6123(08)62241-4.
